1. 257 Contrasting clinical characteristics and treatment patterns in women with newly diagnosed advanced-stage ovarian cancer in Australia, South Korea and Taiwan. (4th December 2020) Authors: Chou, Hung-Hsueh; Defazio, Anna; Kim, Byoung-Gie; Chang, Chih-Long; Bowtell, David; Hsu, Heng-Cheng; Traficante, Nadia; Jeong, Soo Young; Cheng, Wen-Fang; Fereday, Sian Journal: International journal of gynecological cancer Issue: Volume 30(2020)Supplement 4 Page Start: A59 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. BTLA blockade enhances Cancer therapy by inhibiting IL-6/IL-10-induced CD19high B lymphocytes. Issue 1 (21st November 2019) Authors: Chen, Yu-Li; Lin, Han-Wei; Chien, Chung-Liang; Lai, Yen-Ling; Sun, Wei-Zen; Chen, Chi-An; Cheng, Wen-Fang Journal: Journal for immunotherapy of cancer Issue: Volume 7:Issue 1(2019) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. CDH1, DLEC1 and SFRP5 methylation panel as a prognostic marker for advanced epithelial ovarian cancer. (16th October 2018) Authors: Lin, Han-Wei; Fu, Chi-Feng; Chang, Ming-Cheng; Lu, Tzu-Pin; Lin, Hsiu-Ping; Chiang, Ying-Cheng; Chen, Chi-An; Cheng, Wen-Fang Journal: Epigenomics Issue: Volume 10:Number 11(2018) Page Start: 1397 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. CHI3L1 results in poor outcome of ovarian cancer by promoting properties of stem-like cells. Issue 1 (January 2019) Authors: Lin, Han-Wei; Chiang, Ying-Cheng; Sun, Nai-Yun; Chen, Yu-Li; Chang, Chi-Fang; Tai, Yi-Jou; Chen, Chi-An; Cheng, Wen-Fang Journal: Endocrine-related cancer Issue: Volume 26:Issue 1(2019) Page Start: 73 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Demethylation of HIN-1 reverses paclitaxel-resistance of ovarian clear cell carcinoma through the AKT-mTOR signaling pathway. Issue 1 (December 2015) Authors: Ho, Chih-Ming; Huang, Chi-Jung; Huang, Shih-Hung; Chang, Shwu-Fen; Cheng, Wen-Fang Journal: BMC cancer Issue: Volume 15:Issue 1(2015) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Establishment of a New Ovarian Cancer Cell Line CA5171. (June 2015) Authors: Chiang, Ying-Cheng; Cheng, Wen-Fang; Chang, Ming-Cheng; Lu, Tzu-Pin; Kuo, Kuan-Ting; Lin, Hsiu-Ping; Hsieh, Chang-Yao; Chen, Chi-An Journal: Reproductive sciences Issue: Volume 22:Number 6(2015:Jun.) Page Start: 725 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Gene methylation of human ovarian carcinoma stromal progenitor cells promotes tumorigenesis. Issue 1 (December 2015) Authors: Ho, Chih-Ming; Shih, Daniel; Hsiao, Chih-Chiang; Huang, Shih-Hung; Chang, Shwu-Fen; Cheng, Wen-Fang Journal: Journal of translational medicine Issue: Volume 13:Issue 1(2015) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Immune checkpoint Ab enhances the antigen-specific anti-tumor effects by modulating both dendritic cells and regulatory T lymphocytes. (1st March 2019) Authors: Sun, Nai-Yun; Chen, Yu-Li; Lin, Han-Wei; Chiang, Ying-Cheng; Chang, Chi-Fang; Tai, Yi-Jou; Chen, Chi-An; Sun, Wei-Zen; Chien, Chung-Liang; Cheng, Wen-Fang Journal: Cancer letters Issue: Volume 444(2019) Page Start: 20 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Immuno-modulators enhance antigen-specific immunity and anti-tumor effects of mesothelin-specific chimeric DNA vaccine through promoting DC maturation. (1st July 2018) Authors: Chen, Yu-Li; Chang, Ming-Cheng; Chiang, Ying-Cheng; Lin, Han-Wei; Sun, Nai-Yun; Chen, Chi-An; Sun, Wei-Zen; Cheng, Wen-Fang Journal: Cancer letters Issue: Volume 425(2018) Page Start: 152 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Insulin-like growth factors inhibit dendritic cell-mediated anti-tumor immunity through regulating ERK1/2 phosphorylation and p38 dephosphorylation. Issue 1 (1st April 2015) Authors: Huang, Ching-Ting; Chang, Ming-Cheng; Chen, Yu-Li; Chen, Tsung-Ching; Chen, Chi-An; Cheng, Wen-Fang Journal: Cancer letters Issue: Volume 359:Issue 1(2015) Page Start: 117 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗